British equities traded in the red on Thursday, with the FTSE 100 down 0.75% at closing, as crude oil prices increased amid waning optimism over a US-Iran peace deal and heightened geopolitical tensions involving Russia.
UK total vehicle manufacturing fell 11.6% year over year to 63,655 units in July, the Society of Motor Manufacturers and Traders said. Car production declined 10.6% to 61,767 units, while commercial vehicle output dropped 34.4% to 1,888 units.
"July's figures underline the intense pressure under which UK vehicle manufacturers are currently operating. Although the negative performance is exacerbated by shutdown calendarisation and model changeovers, it is being compounded by weaker overseas demand and fierce global competition," SMMT Chief Executive Mike Hawes said.
Meanwhile, Iran has yet to reach terms with Oman for a temporary joint maritime corridor in the Strait of Hormuz, Reuters reported, citing Iranian sources. Russia is also reportedly preparing for further attacks on Ukraine following failed peace negotiations, while concerns over potential hostilities involving Baltic NATO members have added to geopolitical tensions.
In corporate news, AstraZeneca (AZN.L) and Amgen's Tezspire showed statistically significant and clinically meaningful improvements in the symptoms of eosinophilic esophagitis, an immune condition of the esophagus, in high-level results from the phase 3 Crossing trial. AstraZeneca shares slipped 0.70% in the closing session.
Prudential (PRU.L), down 2.45%, expanded its $1.2 billion share repurchase program for 2026 by an additional $300 million. The insurer and asset manager also affirmed expectations for double-digit growth in both adjusted EPS and dividend per share for 2026 after reporting a yearly decline in first-half attributable profit to $954 million from $1.28 billion. Insurance revenue increased to $5.90 billion from $5.33 billion.
Miner South32 (S32.L) climbed 2.07% after attributable profit for the 12 months ended June 30 grew to $1.09 billion from $213 million year over year, while revenue rose to $5.82 billion from $5.78 billion. "FY27 production is unchanged from July while new FY27 unit cost and capex guidance is slightly weaker than expected," RBC Capital Markets said.